{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:07Z","timestamp":1792686427989,"version":"4.5.0"},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:00:00Z","timestamp":1607990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Obstet and Gynaecol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare the sensitivity and specificity of screening for preeclampsia and FGR including maternal characteristics, mean arterial blood pressure and uterine artery pulsatility index and the combined screening, which adds biochemical markers, such as placental growth factor (PlGF) and pregnancy\u2010associated plasma protein\u2010A (PAPP\u2010A), in a sample of high risk population for hypertensive disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a prospective study with 527 singleton pregnancies at 11\u201314\u2009weeks of gestation. Maternal characteristics, biochemical and biophysical markers were studied to determine the development of preeclampsia and FGR by using receiver operating characteristic curves.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For preeclampsia, screening, including sociodemographic data plus biophysical markers, had a sensitivity and specificity of 70.3% (CI% 64.3\u201375.2) and 93.8% (CI% 90.9\u201396.8), respectively. Combined screening, which includes sociodemographic data, biophysical (mean blood pressure and uterine artery pulsatility index) and biochemical markers (PlGF and PAPP\u2010A), increased sensitivity and specificity up to 85.5% (CI% 80.2\u201390.3) and 96.3% (CI% 91.4\u201398.9), respectively. For FGR, sociodemographic data plus biophysical markers had a sensitivity and specificity of 57.8% (CI% 50.1\u201363.4) and 80.1% (CI% 74.3\u201385.9), respectively. Combined screening increased sensitivity and specificity up to 67.2% (CI% 52.1\u201371.3) and 82.7% (CI% 75.2\u201390.1), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Combined screening for preeclampsia and FGR at 11 to 14\u2009weeks of gestation, which includes maternal characteristics, mean blood pressure, uterine artery pulsatility index, PAPP\u2010A and PlGF, has higher sensitivity and specificity than other screening options. Therefore, considering all these variables during screening is recommended for a superior opportunity of identifying pregnant women in risk for preeclampsia and FGR, especially in a high\u2010risk population.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jog.14605","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T02:02:08Z","timestamp":1608084128000},"page":"765-773","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of preeclampsia and fetal growth restriction screenings at first trimester in a high\u2010risk population"],"prefix":"10.1111","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7040-2705","authenticated-orcid":false,"given":"Ximena Carolina","family":"Romero Infante","sequence":"first","affiliation":[{"name":"Universidad El Bosque, Ecodiagn\u00f3stico El Bosque S. A. S, Los Cobos Medical Center El Bosque Research Group of Maternal Fetal Medicine and Gynecology  Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-8633","authenticated-orcid":false,"given":"Montserrat","family":"Uriel","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, Ecodiagn\u00f3stico El Bosque S. A. S, Los Cobos Medical Center El Bosque Research Group of Maternal Fetal Medicine and Gynecology  Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-1388","authenticated-orcid":false,"given":"Alexandra","family":"Porras Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, Los Cobos Medical Center Research Group Medicina Comunitaria y Salud Colectiva  Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4594-9151","authenticated-orcid":false,"given":"Sara","family":"Rinc\u00f3n Franco","sequence":"additional","affiliation":[{"name":"Universidad El Bosque, Ecodiagn\u00f3stico El Bosque S. A. S, El Bosque Research Group of Maternal Fetal Medicine and Gynecology  Bogot\u00e1 Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,12,15]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000362518"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4397"},{"key":"e_1_2_8_4_1","volume-title":"Gu\u00eda de trastornos hipertensivos del embarazo","author":"Secretaria distrital de salud","year":"2014"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.56085\/20277970.20","article-title":"Incidencia De Los Trastornos Hipertensivos En El Embarazo, Y Caracter\u00edsticas Cl\u00ednico\u2010Demogr\u00e1ficas En Tres Instituciones en Bogot\u00e1, D.C., Colombia","volume":"20","author":"Romero XC","year":"2018","journal-title":"Investigaciones en Seguridad Social y Salud"},{"key":"e_1_2_8_6_1","first-page":"000105","article-title":"The reality of preeclampsia in Colombian pregnant women","volume":"1","author":"Uriel M","year":"2016","journal-title":"J Gynecol"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.02.010"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102149"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2011.09.011"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.30554\/archmed.10.2.1293.2010"},{"key":"e_1_2_8_11_1","article-title":"Factores de riesgo de parto prematuro en Bogot\u00e1","volume":"68","author":"Ahumada JS","year":"2020","journal-title":"Colombia Rev fac Med"},{"key":"e_1_2_8_12_1","volume-title":"Task Force on Hypertension in Pregnancy","author":"American College of Obstetricians and Gynecologists","year":"2013"},{"key":"e_1_2_8_13_1","first-page":"e97","article-title":"ACOG Practice Bulletin No. 204: Restricci\u00f2n del crecimiento fetal. United States of America","volume":"133","author":"America College of Obstetricians and Gynecologists","year":"2019","journal-title":"ACOG"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2009.83"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17455"},{"key":"e_1_2_8_16_1","unstructured":"Ministerio de Salud.Gu\u00edas de pr\u00e1ctica Cl\u00ednica para la prevenci\u00f3n detecci\u00f3n temprana y tratamiento de las complicaciones del embarazo parto o puerperio. Colombia: Ministerio de Salud.2013."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.11.001"},{"key":"e_1_2_8_18_1","first-page":"165","article-title":"Predictive factors for intrauterine growth restriction","volume":"7","author":"Albu AR","year":"2014","journal-title":"J Med Life"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2685"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.7628"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.9029"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.11.002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17403"},{"key":"e_1_2_8_24_1","first-page":"608","article-title":"First\u2010trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction","volume":"98","author":"Charas YT","year":"2001","journal-title":"Obstet Gynecol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002564"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000357592"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2017.60.2.154"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1159\/000321694"},{"key":"e_1_2_8_29_1","unstructured":"World Medical Association.WMA Declaration of Helsinki\u2010Ethical Principles for Medical Research Involving Human Subjects. Adopted by the 18th WMA General Assembly Helsinki Finland June 1964.2018. Available from URL:https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"e_1_2_8_30_1","unstructured":"Ministerio de salud.Resoluci\u00f3n 8430 de1993."},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.18597\/rcog.315"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.7439"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2279"},{"key":"e_1_2_8_34_1","first-page":"542","article-title":"Review: Biochemical markers to predict preeclampsia","volume":"26","author":"Anderson UD","year":"2012","journal-title":"Placenta"},{"key":"e_1_2_8_35_1","first-page":"00198","article-title":"Clinical and biochemical markers for preeclampsia","volume":"6","author":"Jasovic\u2010Siveska E","year":"2017","journal-title":"Obstet Gynecol Int"}],"updated-by":[{"DOI":"10.1111\/jog.14894","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["Journal of Obstetrics and Gynaecology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.14605","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jog.14605","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jog.14605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T15:39:21Z","timestamp":1693755561000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/jog.14605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1111\/jog.14605"],"URL":"https:\/\/doi.org\/10.1111\/jog.14605","archive":["Portico"],"relation":{"correction":[{"id-type":"doi","id":"10.1111\/jog.14894","asserted-by":"object"}]},"ISSN":["1341-8076","1447-0756"],"issn-type":[{"value":"1341-8076","type":"print"},{"value":"1447-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,15]]},"assertion":[{"value":"2020-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}